RECRUITING

Genetic Information Assistant in Telegenetics

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to learn about different ways cancer genetic screening can be provided to rural communities in participants at high risk for certain cancers. The main question it aims to answer is: • Does receiving pre-genetic test education with a chat bot or genetic counselor affect if the participant decides to get genetic testing? Participants will: * have a pre-test genetic counselling session with a genetic counselor or the GIA chatbot * answer questions about their cancer genetic knowledge and how they are doing * provide a saliva sample for genetic testing to test for cancer gene mutations * have their genetic testing results provided to them. * have the option to share their genetic testing results with family members Researchers will compare how many participants who had pre-genetic counseling with the chatbot received genetic testing to how many participants who had pre-genetic counseling with a genetic counselor received genetic testing.

Official Title

A Prospective, Randomized Trial to Compare Telegenetics to Counseling Via a Novel Genetic Information Assistant in High-risk Cancer Patients.

Quick Facts

Study Start:2024-07-01
Study Completion:2026-01-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06089421

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * At high risk for having a genetic pathogenic variant as assessed by a GC or physician according to the NCCN guidelines
  2. * Provision of signed and dated informed consent form.
  3. * Stated willingness to comply with all study procedures and availability for the duration of the study.
  4. * Male or female, aged 18 and over.
  5. * Subjects must have a smartphone with access to cellular and/or internet service or a computer with internet service.
  6. * Subjects must have technological competency/proficiency to use their Smartphone and/or computer in conjunction with the communication aid GIA.
  1. * Cannot communicate in English or Spanish.
  2. * Subjects must not have completed panel-based cancer genetic testing in the past.

Contacts and Locations

Study Contact

Graham Fowler
CONTACT
(434) 323-1749
NVG4WM@uvahealth.org
Magnifique Irakoze
CONTACT
(434) 924-9918
rve7xg@virginia.edu

Principal Investigator

Kari Ring, MD
PRINCIPAL_INVESTIGATOR
University of Virginia

Study Locations (Sites)

University of Virginia
Charlottesville, Virginia, 22930
United States

Collaborators and Investigators

Sponsor: University of Virginia

  • Kari Ring, MD, PRINCIPAL_INVESTIGATOR, University of Virginia

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-01
Study Completion Date2026-01-01

Study Record Updates

Study Start Date2024-07-01
Study Completion Date2026-01-01

Terms related to this study

Additional Relevant MeSH Terms

  • Gene Mutation-Related Cancer
  • Genetic Predisposition